2.Comparison of Three Doses of Isobaric Ropivacaine Mixed with Fentanyl during Spinal Anesthesia for Cesarean Section.
Hye Kyoung KIM ; Sang Gon LEE ; Jong Suk BAN ; Byung Woo MIN
Korean Journal of Anesthesiology 2002;43(5):606-610
BACKGROUND: We evaluated the appropriate dose of spinal isobaric 0.75% ropivacaine with fentanyl for cesarean section. METHODS: Forty-five healthy term parturients scheduled for an elective cesarean section randomly received 14, 16, 18 mg of 0.75% isobaric ropivacaine intrathecally, which was mixed with fentanyl 20microgram. Sensory blockade variables such as time to L1 block, max. block height, time to max block height, and time to recovery to L1 were assessed. Motor blockade variables such as time to Bromage scale 3, motor recovery time (Bromage scale 3 to 1) and muscle relaxation were assessed. We also checked side effects, and hemodynamic variables. RESULTS: Anesthesia was successful in 57%, 80%, and 93.3% of groups I (14 mg), II (16 mg), and III (18 mg) respectively and there was no significant difference between the three groups. The time to max. sensory and motor block and level of maximum sensory block were not significantly different between the three groups. All groups showed complete motor block, and muscle relaxation was equally excellent in the three groups. Sensory and motor recovery time were not significantly different. The incidence of hypotension was more frequent in group 3 compared with group 1. The incidence of nausea was more frequent in group 3 compared with group 1, and 2. CONCLUSIONS: An intrathecal injection of 16 mg of isobaric 0.75% ropivacaine with fentanyl 20microgram during spinal anesthesia is suitable for an elective cesarean section.
Anesthesia
;
Anesthesia, Spinal*
;
Cesarean Section*
;
Female
;
Fentanyl*
;
Hemodynamics
;
Hypotension
;
Incidence
;
Injections, Spinal
;
Muscle Relaxation
;
Nausea
;
Pregnancy
3.The expression of FGF-5 and FGF-7 in the cyclosporin a-induced gingival hyperplasia.
Mi Hyang JEONG ; Seong Gon KIM ; Kyoung In YUN ; Dong Seok NAHM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2006;32(3):216-221
Cyclosporin A-induced gingival hyperplasia is frequently found in the patients who have been received an immunosuppressant for the organ transplantation. However, its exact mechanism is still unknown. The expression of FGF-5 and FGF-7 were studied in cyclosporine A-induced gingival hyperplasia (CGH) and inflammatory gingival hyperplasia (IGH). Immunohistochemistry and in situ hybridization were used for localization of protein and mRNA. The expression of FGF-5 and FGF-7 was different from CGH and IGH. FGF-5 and FGF-7 was strongly expressed in fibroblast in CGH (P<0.005 and P<0.05, respectively). FGF-5 mRNA was localized in the middle portion of connective tissue. FGF-7 mRNA was also identified in fibroblasts and mast cells. In conclusion, FGF-5 and FGF-7 were produced excessively by fibroblasts in CGH. Considering their known functions, their expression in CGH is important for production of collagen and proliferation of fibroblasts.
Collagen
;
Connective Tissue
;
Cyclosporine*
;
Fibroblasts
;
Gingival Hyperplasia*
;
Humans
;
Immunohistochemistry
;
In Situ Hybridization
;
Mast Cells
;
Organ Transplantation
;
RNA, Messenger
;
Transplants
4.Comparison of 67Ga planar imaging and SPECT for the evaluation of activity in undetermined minimal pulmonary tuberculosis.
Min AN ; Won Kyu CHANG ; Kyoung Gon KIM ; Sung Min KIM ; Yun Kwon KIM ; Young Jung KIM ; Byung Yik PARK ; Min Koo CHO ; Gwon Jun LEE
Tuberculosis and Respiratory Diseases 2000;48(6):870-878
BACKGROUND: We have studied the 67Ga SPECT to determine the activity of pulmonary tuberculosis, especially in patients with minimal extent of the disease on chest radiographs. Because active minimal pulmonary tuberculosis is sometimes difficult to diagnose by means of initial chest X-ray, sputum examination and 67Ga planar imaging, we compared 67Ga planar imaging with SPECT to evaluate minimal pulmonary tuberculosis activity. METHODS: 67Ga planar imagings and SPECTs of 69 patients suspected of minimal pulmonary tuberculosis by the initial chest X-ray were performed and compared to each other. Active pulmonary tuberculosis was defined by a positive AFB smear and/or culture in the sputum and changes shown on the serial chest X-ray findings. RESULTS: 1)67Ga planar imaging imagings showed positive uptakes in 24 patients and no uptakes in 13 patients, which confirms active pulmonary tuberculosis. But SPECT imagings showed positive uptakes in 25 patients and no uptakes in 12 patients. 2) Patients confirmed with inactive pulmonary tuberculosis showed no up-take on 67Ga planar imaging. Only one of the 32 patients confirmed as having inactive pulmonary tuberculosis showed positive uptake on 67Ga SPECT imaging. CONCLUSIONS: According to the results of our study, 67Ga planar imaging and SPECT are both sensitive in detecting the activity of minimal pulmonary tuberculosis. The difference between the two methods is not statistically significant, and the negative predictive value of the 67Ga SPECT is not higher than that of 67Ga planar imaging.
Humans
;
Radiography, Thoracic
;
Sputum
;
Thorax
;
Tomography, Emission-Computed, Single-Photon*
;
Tuberculosis, Pulmonary*
5.Treatment Patterns and Preferences for Graves’ Disease in Korea: Insights from a Nationwide Cohort Study
Kyeong Jin KIM ; Jimi CHOI ; Soo Myoung SHIN ; Jung A KIM ; Kyoung Jin KIM ; Sin Gon KIM
Endocrinology and Metabolism 2024;39(4):659-663
Treatment patterns and preferences for patients with Graves’ disease (GD) vary across countries. In this study, we assessed the initial therapies and subsequent treatment modalities employed for GD in real-world clinical practice in Korea. We analyzed 452,001 patients with GD from 2004 to 2020, obtained from the Korean National Health Insurance Service database. Initial treatments included antithyroid drug (ATD) therapy (98% of cases), thyroidectomy (1.3%), and radioactive iodine (RAI) therapy (0.7%). The rates of initial treatment failure were 58.5% for ATDs, 21.3% for RAI, and 2.1% for thyroidectomy. Even among cases of ATD treatment failure or recurrence, the rates of RAI therapy remained low. Regarding initial treatment, the 5-year remission rate was 46.8% among patients administered ATDs versus 91.0% among recipients of RAI therapy; at 10 years, these rates were 59.2% and 94.0%, respectively. Our findings highlight a marked disparity in the use of RAI therapy in Korea compared to Western countries. Further research is required to understand the reasons for these differences in treatment patterns.
6.Treatment Patterns and Preferences for Graves’ Disease in Korea: Insights from a Nationwide Cohort Study
Kyeong Jin KIM ; Jimi CHOI ; Soo Myoung SHIN ; Jung A KIM ; Kyoung Jin KIM ; Sin Gon KIM
Endocrinology and Metabolism 2024;39(4):659-663
Treatment patterns and preferences for patients with Graves’ disease (GD) vary across countries. In this study, we assessed the initial therapies and subsequent treatment modalities employed for GD in real-world clinical practice in Korea. We analyzed 452,001 patients with GD from 2004 to 2020, obtained from the Korean National Health Insurance Service database. Initial treatments included antithyroid drug (ATD) therapy (98% of cases), thyroidectomy (1.3%), and radioactive iodine (RAI) therapy (0.7%). The rates of initial treatment failure were 58.5% for ATDs, 21.3% for RAI, and 2.1% for thyroidectomy. Even among cases of ATD treatment failure or recurrence, the rates of RAI therapy remained low. Regarding initial treatment, the 5-year remission rate was 46.8% among patients administered ATDs versus 91.0% among recipients of RAI therapy; at 10 years, these rates were 59.2% and 94.0%, respectively. Our findings highlight a marked disparity in the use of RAI therapy in Korea compared to Western countries. Further research is required to understand the reasons for these differences in treatment patterns.
7.Treatment Patterns and Preferences for Graves’ Disease in Korea: Insights from a Nationwide Cohort Study
Kyeong Jin KIM ; Jimi CHOI ; Soo Myoung SHIN ; Jung A KIM ; Kyoung Jin KIM ; Sin Gon KIM
Endocrinology and Metabolism 2024;39(4):659-663
Treatment patterns and preferences for patients with Graves’ disease (GD) vary across countries. In this study, we assessed the initial therapies and subsequent treatment modalities employed for GD in real-world clinical practice in Korea. We analyzed 452,001 patients with GD from 2004 to 2020, obtained from the Korean National Health Insurance Service database. Initial treatments included antithyroid drug (ATD) therapy (98% of cases), thyroidectomy (1.3%), and radioactive iodine (RAI) therapy (0.7%). The rates of initial treatment failure were 58.5% for ATDs, 21.3% for RAI, and 2.1% for thyroidectomy. Even among cases of ATD treatment failure or recurrence, the rates of RAI therapy remained low. Regarding initial treatment, the 5-year remission rate was 46.8% among patients administered ATDs versus 91.0% among recipients of RAI therapy; at 10 years, these rates were 59.2% and 94.0%, respectively. Our findings highlight a marked disparity in the use of RAI therapy in Korea compared to Western countries. Further research is required to understand the reasons for these differences in treatment patterns.
8.Treatment Patterns and Preferences for Graves’ Disease in Korea: Insights from a Nationwide Cohort Study
Kyeong Jin KIM ; Jimi CHOI ; Soo Myoung SHIN ; Jung A KIM ; Kyoung Jin KIM ; Sin Gon KIM
Endocrinology and Metabolism 2024;39(4):659-663
Treatment patterns and preferences for patients with Graves’ disease (GD) vary across countries. In this study, we assessed the initial therapies and subsequent treatment modalities employed for GD in real-world clinical practice in Korea. We analyzed 452,001 patients with GD from 2004 to 2020, obtained from the Korean National Health Insurance Service database. Initial treatments included antithyroid drug (ATD) therapy (98% of cases), thyroidectomy (1.3%), and radioactive iodine (RAI) therapy (0.7%). The rates of initial treatment failure were 58.5% for ATDs, 21.3% for RAI, and 2.1% for thyroidectomy. Even among cases of ATD treatment failure or recurrence, the rates of RAI therapy remained low. Regarding initial treatment, the 5-year remission rate was 46.8% among patients administered ATDs versus 91.0% among recipients of RAI therapy; at 10 years, these rates were 59.2% and 94.0%, respectively. Our findings highlight a marked disparity in the use of RAI therapy in Korea compared to Western countries. Further research is required to understand the reasons for these differences in treatment patterns.
9.The Mechanism of Intracellular Signal Pathway that Baicalin Hydrate Elevate Chemotherapeutic Response of Cervical Carcinoma.
Byoung Ryun KIM ; In Suk KIM ; Kyoung Hee KO ; Je Jung LEE ; Heung Gon KIM ; Rae Gil PARK
Korean Journal of Obstetrics and Gynecology 2003;46(10):1965-1974
Baicalin is flavonoid and major component of PC-SPES. Flavonoids including baicalin have been reported to not only function as anti-oxidant but also cause cytotoxic effect. Baicalin hydrate has been reported to induce cell death, however the mechanism by which baicalin hydrate induces the apoptosis of cancer cells is still unclear. To evaluate the mechanistic insights of apoptosis by baicalin hydrate, we tested the activities of apoptosis signaling pathway in HeLa cells. The viability of HeLa and HeLa s3 cells was markedly decreased by baicalin hydrate in a dose- and time- dependent method. Baicalin hydrate induced the apoptotic death of HeLa cells, which was characterized by the chromatin condensation of the nuclei and phosphorylation of histone H2AX. Baicalin hydrate increased the sub-G1 DNA content of HeLa cell lines. Baicalin hydrate digested Bid protein, increased Bak protein level and also, induced mitochondrial dysfunction disrupted as shown as the mitochondrial membrane potential. It activated caspase-3, thereby resulted in cleavage of poly (ADP) ribose polymerase (PARP).
Apoptosis
;
bcl-2 Homologous Antagonist-Killer Protein
;
BH3 Interacting Domain Death Agonist Protein
;
Caspase 3
;
Cell Death
;
Chromatin
;
DNA
;
Flavonoids
;
HeLa Cells
;
Histones
;
Humans
;
Membrane Potential, Mitochondrial
;
Phosphorylation
;
Ribose
;
Signal Transduction*
10.A Case Report of Balloon Angioplasty for Coarctation of Aorta in Adult.
Jin Ok JEONG ; Yoon Cheol KIM ; Bo Young SUNG ; Jun Kyoung KIM ; Jun Yong JEONG ; Jeong Gon LYU ; Si Wan CHOI ; In Whan SEONG ; Eun Seok JEON
Korean Circulation Journal 1997;27(6):677-681
For the treatment of coarction of aorta, surgical intervention has been known as a standard therapy.During last decade balloon angioplasty for coarctation of the aorta has been reported as a successful and safe procedure in about 300 cases. This angioplasty was done mainly in infants and children, and little cases in adults and adolescents. A 22 year-old adult with coarctation of aorta have recieved balloon angioplasty. He visited to emergency room due to severe headache and the blood presure of arm was 240/130mmHg at emergency room. The blood pressure at ward was 168/92mmHg in upper extremities, 104/82mmHg in lower extrimities. His aortogram showed coarctation of thoracic aorta below left subclavian artery. The pressure gradient beween ascending aorta and right femoral artery was decreased from 60mmHg to 0mmHg after balloon dilatation (2 times, balloon diameter 18mm). There were no significant complications. The follow-up magnetic resonance image in 4 month after balloon angioplasty showed no evidence of restenosis or saccular aneurysm. Initial hypertension turned to normal blood pressure in 4 months after balloon angioplasty. This adult case of successful balloon angioplasty for coarctation of aorta is the first case reported in Korea.
Adolescent
;
Adult*
;
Aneurysm
;
Angioplasty
;
Angioplasty, Balloon*
;
Aorta
;
Aorta, Thoracic
;
Aortic Coarctation*
;
Arm
;
Blood Pressure
;
Child
;
Dilatation
;
Emergency Service, Hospital
;
Femoral Artery
;
Follow-Up Studies
;
Headache
;
Humans
;
Hypertension
;
Infant
;
Korea
;
Subclavian Artery
;
Upper Extremity
;
Young Adult